Adalimumab
Information about Adalimumab
Adalimumab Uses
Adalimumab is used in the treatment of Ulcerative colitis, Crohn’s disease, psoriasis, ankylosing spondylitis and rheumatoid arthritis.
How Adalimumab works
Adalimumab blocks the action of certain chemical messengers that are responsible for inflammation, swelling and redness associated with certain joint diseases.
Common side effects of Adalimumab
Sinus inflammation, Upper respiratory tract infection, Injection site reactions (pain, swelling, redness), Infection
Available Medicine for Adalimumab
AdfrarTorrent Pharmaceuticals Ltd
₹10500 to ₹250002 variant(s)
AdalyGlenmark Pharmaceuticals Ltd
₹249001 variant(s)
EnviraEmcure Pharmaceuticals Ltd
₹234371 variant(s)
MaburaHetero Drugs Ltd
₹250001 variant(s)
PlamumabCipla Ltd
₹263531 variant(s)
AdalimacMacleods Pharmaceuticals Pvt Ltd
₹223211 variant(s)
AdalirelReliance Life Sciences
₹11000 to ₹220002 variant(s)
MabvinraAlkem Laboratories Ltd
₹9999 to ₹239992 variant(s)
CipleumabCipla Ltd
₹180001 variant(s)
AdlumabRPG Life Sciences Ltd
₹250001 variant(s)
Expert advice for Adalimumab
- It is given by injection under the skin (via subcutaneous).
- Take it as per the dose and duration suggested by the doctor.
- Inform your doctor immediately if you notice severe rash, hives, swelling of hands or face and shortness of breath.
- Store the pen in the refrigerator. When refrigeration is not possible, you can also keep your pen at room temperature (less than 30°C) for up to 2 weeks. Do not freeze it.
- Do not stop taking the medication suddenly without talking to your doctor first.